SCHEDULE: Intracoastal Capital Takes 9.99% Stake in Longeveron

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, disclosed a 9.99% beneficial ownership stake in Longeveron Inc.'s Class A Common Stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have reported beneficial ownership of 2,143,418 shares of Longeveron Inc. Class A Common Stock.
• This ownership represents approximately 9.99% of the outstanding Class A Common Stock.
• The beneficial ownership includes shares issuable upon exercise of Intracoastal Warrant 1.
• The calculation of beneficial ownership is based on 13,694,570 shares outstanding as of August 8, 2025, plus 5,617,648 shares issued at the closing of the Securities Purchase Agreement (SPA) and 2,143,418 shares issuable from Intracoastal Warrant 1.
• The Reporting Persons hold shared voting and dispositive power over all 2,143,418 shares.
• The acquisition of these securities was not for the purpose of changing or influencing the control of Longeveron Inc.

Sentiment

Score: 5

Explanation: The filing is a standard disclosure of beneficial ownership, indicating a significant but passive investment. It does not contain information that would strongly sway sentiment positively or negatively beyond the fact of the investment itself.

Positives

• A significant institutional investor, Intracoastal Capital LLC, has taken a substantial 9.99% stake in Longeveron Inc., potentially signaling confidence in the company's long-term prospects.
• The investment is structured with blocker provisions, indicating a passive investment strategy rather than an activist one, which can provide stability.

Negatives

• The presence of blocker provisions on multiple warrants (Intracoastal Warrant 1, 2, 3, and 4) limits the immediate exercisability of a larger portion of potential shares, capping the beneficial ownership at 9.99% or 4.99% for different warrants.
• Without these blocker provisions, the Reporting Persons would have beneficial ownership of 4,074,820 shares, indicating a larger potential dilution or influence that is currently restricted.

Risks

• The blocker provisions on warrants (Intracoastal Warrant 1, 2, 3, and 4) prevent the holder from exercising them to the extent that such exercise would result in beneficial ownership exceeding 9.99% (for Warrant 1) or 4.99% (for Warrants 2, 3, 4), which could limit the investor's ability to fully capitalize on potential share price appreciation through warrant exercise.
• Future exercise of warrants, even with blocker provisions, could still lead to some level of share dilution for existing shareholders.

Future Outlook

NA

Industry Context

This filing indicates a significant investment by a capital firm in a publicly traded company, which is a common occurrence in the financial markets. The specific industry of Longeveron Inc. (biotechnology/healthcare, given its name) suggests that such investments are often made with a long-term view on potential drug development or therapeutic advancements.

Stakeholder Impact

• Shareholders: The disclosure of a significant 9.99% stake by a capital firm could be viewed positively as a vote of confidence, but the existence of blocker provisions limits the immediate impact of potential warrant exercises on the share count.
• Company Management: The investment provides capital to the company, supporting its operations and strategic initiatives.

Key Dates

Keywords

Longeveron Inc., Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, Beneficial Ownership, Class A Common Stock, Warrants, Equity Stake, SEC Filing